TABLE 3.
Mutant | GM1 bindinga |
Blood sugar bindingc |
E. coli surface bindingd |
|||
---|---|---|---|---|---|---|
% | P valueb | % | P value | % | P value | |
LT[L25E] | 69.3 ± 5.3e | <0.005 | 64.2 ± 7.2 | <0.01 | 35.2 ± 10.9 | <0.005 |
LT[Q3K]f | 96.0 ± 4.6 | 0.43 | 0.67 ± 0.43 | <0.005 | 33.8 ± 8.8 | <0.005 |
LT[Q3A] | 95.5 ± 14.4 | 0.77 | 4.0 ± 4.0 | 2.3 × 10−6 | 36.5 ± 4.7 | <0.0005 |
LT[E11K] | 90.9 ± 4.6 | 0.08 | 109.6 ± 17.8 | 0.65 | 19.6 ± 9.3 | <0.001 |
LT[E11A] | 81.5 ± 6.5 | 0.07 | ||||
CTB[Q3K] | 93.1 ± 1.9 | <0.05 | ||||
CTB[E11K] | 94.7 ± 2.5 | 0.08 | ||||
CTB[E11A] | 106.7 ± 1.8 | <0.05 |
Purified toxin binding to GM1 was determined by ELISA; values are expressed as mean percentages of wild-type LT or CTB binding ±SEM (n ≥ 3).
P values are for comparison to wild-type binding as determined by Student's t test.
Purified toxin binding to blood group A trisaccharide conjugated to BSA was determined by ELISA; values are expressed as mean percentages of wild-type binding ±SEM (n ≥ 2).
Purified toxin binding to the surface of DH5α E. coli cells was determined by a previously described immunoblot-based binding assay (26); values are expressed as mean percentages of wild-type LT binding ±SEM (n ≥ 3).
Significant differences from wild-type (P < 0.05) are in bold.
Data for this mutant were reported previously (26).